Rare diseases
Investigational molecules
Locations
Back to Bulgaria11 clinical trials in Sandanski, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
BulgariaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
BulgariaStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
BulgariaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
BulgariaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
BulgariaA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
BulgariaStudy of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy
BulgariaStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on innovative treatments for atherosclerotic cardiovascular disease and acute cardiac conditions, evaluating new therapeutic approaches to prevent major cardiovascular events.
Multiple trials investigating self-administered medications for acute cardiac events and preventive therapies for high-risk patients.
Research examining the effectiveness of combination therapies for Chronic Obstructive Pulmonary Disease, focusing on improved treatment outcomes and patient quality of life.
Innovative studies comparing various therapeutic combinations to optimize COPD management strategies.
Clinical investigations into treatments for chronic kidney disease with concurrent hypertension, evaluating combination therapies to slow disease progression.
Comprehensive research examining innovative drug combinations to improve outcomes in patients with complex kidney conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
